Position in ASRT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$74,314
+$57,889 QoQ
Shares Held
3,899
+115.3% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASRT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $619,344,789 across 33 Drug Manufacturers - Specialty & Generic names. ASRT ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
300,204 | $178,014,967 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
1,336,313 | $64,343,470 | |
| 3 | ZTS |
Zoetis Inc.
|
440,797 | $52,106,613 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
350,710 | $46,202,535 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,391,612 | $42,416,333 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
617,072 | $34,130,252 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
2,408,761 | $33,361,339 | |
| 8 | VTRS |
Viatris Inc
|
2,042,257 | $27,590,892 |
All Filings in ASRT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,314 | 3,899 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $16,425 | 1,811 | Shares | Defined | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||